Document is current
Any future updates will be listed below
-
Authors
Kreissl, Michael C.
Wuestemann, Jan
Eppard, Elisabeth
Hescheler, Daniel
Wybranska, Joanna
Kupitz, Dennis
Reissig, Falco
Almaguel, Frankis G.
Notni, Johannes
-
Funding
Funding for this research was provided by:
Technische Universität München
- License Information
-
More Information
Article History
Received: 16 January 2026
Accepted: 20 February 2026
First Online: 26 February 2026
Declarations
:
: This study was conducted in accordance with the principles of the 1964 Declaration of Helsinki and its subsequent amendments, as well as the institutional ethical standards.
: The authors affirm that the patient provided written informed consent for publication of the images.
: The authors affirm that the patient provided written informed consent prior to the procedure and the scientific evaluation of the data.
: Johannes Notni is co-inventor of patents related to αvβ6-integrin targeted radiopharmaceuticals; co-founder, shareholder, and CEO of TRIMT GmbH (Radeberg, Germany). Michael C. Kreissl is advisor of TRIMT GmbH. All other authors declare that they have no competing interests.
